Trial intelligence / Profile preview

Intracameral epinephrine concentration comparison after phacoemulsification

IRCT20141019019581N5Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Sep 2011
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, double-blind trial of epinephrine in cataract (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Corneal endothelial cell number and characteristics and Macular thickness. Started Sep 2011; status: completed.

02

Drugs

epinephrine
03

Conditions

cataract

Beyond the preview

Go deeper on IRCT20141019019581N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20141019019581N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call